PSA welcomes refreshed National Medicines Policy

20 December 2022


The Pharmaceutical Society of Australia (PSA) welcomes the updated National Medicines Policy, announced today by Minister for Health and Aged Care, the Hon Mark Butler MP.


The National Medicines Policy is a framework for ensuring Australians have timely access to affordable, quality medicines that are used appropriately.


The refreshed plan elevates the need to address access challenges, particularly equity and equality for all Australians, and is consistent with PSA’s plan for the future, Pharmacists in 2023, placing patients at the centre of care supported by pharmacists as medicine experts wherever medicines are prescribed, supplied or administered.


Dr Fei Sim, National President of PSA, congratulated Professor Michael Kidd AM on delivering an improved policy which meets the contemporary needs of Australians.


“Medicines are our most common intervention in health care. It is essential that Australians have access to quality and affordable medicines when they need them.” said Dr Sim.


“PSA has long advocated for the NMP to be reviewed, so we are very pleased to see the Minister deliver on this today. We welcome support for national pharmacovigilance systems, however it is crucial that these systems be nationally coordinated and real-time in order to significantly reduce harms which can be caused by medicines.


“We also welcome the recognition that clinical indicators will need to be used to evaluate policy, as this is something else PSA has been fighting for over many years. It is great to see Minister Butler commit to regular 5-yearly reviews to ensure the NMP remains up to date.


“PSA has long been concerned about the preventable harm caused by medicines and has driven the conversation on medicine safety in Australia. We are excited to see changes in policy which should help drive solutions and improve medicine safety for all Australians and look forward to partnering with the government and other organisations to deliver on the goals of this policy.


PSA would like to thank the Expert Advisory Committee members including Emeritus Professor Lloyd Sansom AO, Dr Sarah Dineen-Griffin MPS, Mr David Herd, and Mrs Jan Donovan for their contributions.


Media contact:   Candice Burch M: 0403 973 097     E: Candice.burch@psa.org.au

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.